Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GNT Pharma, TTC enter into strategic partnership in Japan
TTC will represent GNT exclusively in Japan in promoting its products and technologies in the area of new drug discovery for neurological and inflammatory diseases. The alliance with
TTC will represent GNT exclusively in Japan in promoting its products and technologies in the area of new drug discovery for neurological and inflammatory diseases. The alliance with
The patent was initially set to expire in May 2026 and latter was granted a patent term adjustment that extends the expiry date to February 2028, the company
Clotamin is an over-the-counter multivitamin product designed for use by patients on Warfarin or other anticoagulants (blood thinners). Under terms of the agreement, DS Healthcare will evaluate the
The plan includes creation of Special Economic Zone and measures to be taken to attract companies into the state with the help of pharmacy colleges, chemists and druggists
The REGENX program consists of a NAV rAAV8 vector expressing a normal copy of the human low-density lipoprotein receptor (hLDLR) gene. The study, conducted at University of Pennsylvania
Carbonic anhydrase IX, or CAIX, is a transmembrane protein whose expression is restricted to few normal tissues. Under hypoxic conditions, hypoxia inducible factor-1 alpha (HIF-1a) is stabilized and
ColonSentry requires a small blood sample and utilizes RNA to measure the level of expression of seven specific genes. Enzo president Barry Weiner said ColonSentry recently received New
The trials evaluated blood levels of MoxDuo CR’s components to OxyContin and MS Contin and demonstrated MoxDuo CR’s superior results, with sustained blood levels for up to 24
Palivizumab is a humanized monoclonal antibody that binds to respiratory syncytial virus (RSV) glycoprotein fusion protein (F), and inhibits viral entry into cells, thereby reducing RSV associated hospitalizations.
The trial will enroll approximately 400 patients undergoing cataract surgery or refractive lens exchange. The randomized, double-blind, placebo-controlled trial will evaluate the efficacy and safety measures and data